Voor zorgverleners

Artikel31 okt 2025

Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk

People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.¹ The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.^2,3

Bekijk meer

Artikel24 okt 2025

Understanding Autoimmune T1D & The Value of Early Detection

Autoimmune Type 1 Diabetes (T1D) can be detected through islet autoantibody testing years before symptoms appear.^1-2The video here explains how the condition progresses silently through presymptomatic stages, with beta cell destruction occurring long before symptom onset and clinical diagnosis.^4-8

Bekijk meer

Artikel13 okt 2025

When a Child Gets Autoimmune Type 1 Diabetes

Parent's experiences of stage 3 diagnosis of T1D.

Bekijk meer

Artikel9 okt 2025

Sleep and QOL: the full impact on patients coping with the burden of AD

Understanding the full scope of AD—the unseen burden on patients.

Bekijk meer

Artikel6 okt 2025

Can autoimmune type 1 diabetes be detected years before symptom onset?

Autoimmune type 1 diabetes (T1D) is a progressive disease in which the decline in beta cell function usually begins months or sometimes years before clinical symptoms are observed.^1–3 You can identify such patients at risk of developing autoimmune T1D before clinical symptoms are noticed by you or your patient.³

Bekijk meer

Artikel6 okt 2025

Does your patient have an existing autoimmune condition? Check for autoimmune type 1 diabetes!

Individuals living with other associated autoimmune diseases like celiac disease or autoimmune thyroid disease, are at an increased risk of developing autoimmune type 1 diabetes (T1D) and should be appropriately screened.^1-6

Bekijk meer

Artikel6 okt 2025

Early detection of autoimmune type 1 diabetes could reduce the risk of diabetic ketoacidosis

Delay in screening for autoimmune type 1 diabetes (T1D) can increase the risk of diabetic ketoacidosis (DKA) at diagnosis—a critical complication that is potentially life-threatening and may result in long-term poor glycemic control and neurological complications.^1,2 By identifying autoimmune T1D early, you can significantly lower the risk of DKA at diagnosis.^3,4

Bekijk meer

Artikel6 okt 2025

How should individuals with positive autoimmune T1D autoantibodies be monitored over time?

Individuals who screen positive for ≥1 autoimmune islet cell antibodies need periodic medical monitoring, which includes regular assessments of blood glucose and HbA1c levels. You can also educate them about symptoms of diabetes, diabetic ketoacidosis (DKA), and provide psychosocial support to prepare them for a possible clinical diagnosis for type 1 diabetes (T1D).¹

Bekijk meer

Artikel6 okt 2025

Autoimmune Type 1 Diabetes

The Type 1 Diabetes (T1D) field is evolving. Recognition of the presymptomatic stages in T1D is growing.^1-4The clinical benefits of early detection of T1D are being highlighted.^3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.^1,2

Bekijk meer